Lexicon Pharmaceuticals Pfizer: Which Stock Is Best Buy 2026
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Increasing your credit card rewards earnings is easier than you think. Explore simple strategies to enhance your rewards quickly.
21,216 articlesIn 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
As oil prices rebound in 2026, investors weigh the three biggest U.S. oil majors. This report outlines buy, sell or h...
Cerebras just pulled biggest IPO momentum sent shockwaves through tech stocks. This article breaks down what that imp...
Salesforce and Oracle just posted earnings in a tight window, spotlighting two distinct AI and cloud bets. This piece...
A week after Walmart’s investor day, the stock surged as analysts highlighted margin discipline and cash returns. Thi...
Intel faces a pivotal moment as Q1 losses mount and cash burn deepens. Analysts and investors debate buy, hold sell i...
As AI use expands from training to real-world deployment, memory players like Micron face a pivotal moment. This arti...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Microsoft sits at a pivotal price near $420 as quarterly results underscore AI momentum and capex intensity. This rep...
Alphabet plans nearly $185B in capital spending for 2026, mostly on data centers. This article highlights a crucial m...
As 2026 unfolds, a new government analysis finds that majors tied to real-world demand offer strong pay and job stabi...